Intellia Therapeutics, Inc. (LON: 0JBU)
London
· Delayed Price · Currency is GBP · Price in USD
10.26
-0.26 (-2.43%)
At close: Jan 31, 2025
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of 845.60 million as of January 31, 2025. Its market cap has decreased by -53.54% in one year.
Market Cap
845.60M
Enterprise Value
167.35M
Revenue
32.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.26
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from 537.16M to 845.60M, an increase of 57.42%. That is a compound annual growth rate of 5.33%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.89B |
GSK plc | 57.33B |
Haleon | 33.92B |
Smith & Nephew | 9.00B |
Hikma Pharmaceuticals | 5.08B |
ConvaTec Group | 5.06B |
HUTCHMED (China) | 1.88B |
Oxford Nanopore Technologies | 1.39B |